Correlation between Triglyceride Glucose Index and Diabetic Kidney in Type 2 Diabetic: Literature Review
DOI:
https://doi.org/10.33096/gmj.v6i3.195Kata Kunci:
Triglyceride-Glucose (TyG) Index, diabetic kidney disease (DKD), type 2 diabetes mellitusAbstrak
Introduction: One marker of insulin resistance in type 2 diabetes is the triglyceride index (TyG), which has been studied to predict the development of diabetic kidney disease (DKD). This study investigates the correlation between the triglyceride glucose index and diabetic kidney disease in type 2 diabetes mellitus.
Methods: A comprehensive search was conducted in PubMed, Proquest, ScienceDirect, Taylor and Francis, Cochrane Library and Google Scholar search using search terms including (‘‘Triglyceride Glucose Index or TyG’’) and (‘‘Diabetic Kidney or Diabetic Nephropathy’’) and ("Diabetes Mellitus" OR "Diabetes Mellitus Type II" OR "Type 2 Diabetes Mellitus").
Results: A total of 8 studies were screened based on titles and abstracts, of which 7 studies were included in the analysis of TyG and DKD. A prediction model including the TyG index demonstrated excellent calibration and discrimination for the probability of DKD in research involving patients recently diagnosed with type 2 diabetes mellitus (T2DM). This approach has potential applications in clinical practice. DKD and metabolic diseases are independently correlated with the TyG index. Recently, one sensitive method for identifying DKD with insulin resistance has been the TyG index. The TyG index is a readily available, affordable, and simple marker for identifying of microvascular problems in T2DM patients.
Conclusion: In our review, TyG and DKD were significantly positively correlated in patients with type 2 diabetic mellitus. TyG index has potential as a practical tool for determining insulin resistance and predicting the probabilities that individuals with type 2 diabetes are related to diabetic kidney disease.
Referensi
International Diabetes Federation. IDF Diabetes Atlas 10th edition. n.d.
Hoogeveen EK. The Epidemiology of Diabetic Kidney Disease. Kidney and Dialysis 2022;2:433–42. https://doi.org/10.3390/kidneydial2030038.
Poloni JAT, Rotta LN. Diabetic kidney disease: Pathophysiological changes and urinalysis contribution to diagnosis-a narrative review. J Lab Precis Med 2022;7. https://doi.org/10.21037/jlpm-21-20.
Jha R, Lopez-Trevino S, Kankanamalage HR, Jha JC. Diabetes and Renal Complications: An Overview on Pathophysiology, Biomarkers and Therapeutic Interventions. Biomedicines 2024;12. https://doi.org/10.3390/biomedicines12051098.
Wang H, Chen G, Sun D, Ma Y. The threshold effect of triglyceride glucose index on diabetic kidney disease risk in patients with type 2 diabetes: unveiling a non-linear association. Front Endocrinol (Lausanne) 2024;15. https://doi.org/10.3389/fendo.2024.1411486.
Schrauben SJ, Jepson C, Hsu JY, Wilson FP, Zhang X, Lash JP, et al. Insulin resistance and chronic kidney disease progression, cardiovascular events, and death: Findings from the chronic renal insufficiency cohort study. BMC Nephrol 2019;20. https://doi.org/10.1186/s12882-019-1220-6.
Freeman AM, Acevedo LA, Pennings N. Insulin Resistance . Ncbi 2023. https://www.ncbi.nlm.nih.gov/books/NBK507839/ (accessed September 5, 2024).
Jiang Y, Lai X. Association between the triglyceride glucose index, triglyceride-glucose body mass index and diabetic kidney disease in adults with newly diagnosed type 2 diabetes. Front Med (Lausanne) 2024;11. https://doi.org/10.3389/fmed.2024.1328601.
Shang J, Yu D, Cai Y, Wang Z, Zhao B, Zhao Z, et al. The triglyceride glucose index can predict newly diagnosed biopsy-proven diabetic nephropathy in type 2 diabetes: A nested case control study. Medicine 2019;98:e17995. https://doi.org/10.1097/MD.0000000000017995.
KDIGO. Official JOurnal Of the internatiOnal SOciety Of nephrOlOgy KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. 2013.
Flake CC, Morales-Valenzuela M, Tiongco RE, Navarro A. Profiling triglyceride-glucose index in Filipinos with type 2 diabetes mellitus: a single-center study. Egypt J Intern Med 2024;36. https://doi.org/10.1186/s43162-024-00294-9.
Gao YM, Chen WJ, Deng ZL, Shang Z, Wang Y. Association between triglyceride-glucose index and risk of end-stage renal disease in patients with type 2 diabetes mellitus and chronic kidney disease. Front Endocrinol (Lausanne) 2023;14. https://doi.org/10.3389/fendo.2023.1150980.
Thomas SS, Zhang L, Mitch WE. Molecular mechanisms of insulin resistance in chronic kidney disease. Kidney Int 2015;88:1233–9. https://doi.org/10.1038/ki.2015.305.
Whaley-Connell A, Sowers JR. Insulin Resistance in Kidney Disease: Is There a Distinct Role Separate from That of Diabetes or Obesity. Cardiorenal Med 2017;8:41–9. https://doi.org/10.1159/000479801.
Li HF, Miao X, Li Y. Influence of Insulin Resistance on Diabetes Nephropathy. Medical Science Monitor 2023;29. https://doi.org/10.12659/MSM.939482.
Lv L, Zhou Y, Chen X, Gong L, Wu J, Luo W, et al. Relationship between the tyg index and diabetic kidney disease in patients with type-2 diabetes mellitus. Diabetes, Metabolic Syndrome and Obesity 2021;14:3299–306. https://doi.org/10.2147/DMSO.S318255.
Tu Z, Du J, Ge X, Peng W, Shen L, Xia L, et al. Triglyceride Glucose Index for the Detection of Diabetic Kidney Disease and Diabetic Peripheral Neuropathy in Hospitalized Patients with Type 2 Diabetes. Diabetes Therapy 2024;15:1799–810. https://doi.org/10.1007/s13300-024-01609-3.
Liu L, Xia R, Song X, Zhang B, He W, Zhou X, et al. Association between the triglyceride–glucose index and diabetic nephropathy in patients with type 2 diabetes: A cross-sectional study. J Diabetes Investig 2021;12:557–65. https://doi.org/10.1111/jdi.13371.
Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci 2020;21:1–34. https://doi.org/10.3390/ijms21176275.
Antar SA, Ashour NA, Sharaky M, Khattab M, Ashour NA, Zaid RT, et al. Diabetes mellitus: Classification, mediators, and complications; A gate to identify potential targets for the development of new effective treatments. Biomedicine and Pharmacotherapy 2023;168. https://doi.org/10.1016/j.biopha.2023.115734.
